Cancers MDPI

@cancers-mdpi.bsky.social

Cancers (IF: 4.8, ISSN 2072-6694) an international #openaccess journal addressing both clinical and basic science issues related to #cancer research.

@cancers-mdpi.bsky.social Oct 9, 2026, 8:21 AM

👏Pleased to share the new journal Breast Cancer Research and Care (BCRC)!

👤Editor-in-Chief: Prof. Dr. Kay-Uwe Wagner

📖 Read the Editorial: www.mdpi.com/3043-100X/1/...

#BreastCancer #BCRCMDPI #prevention #detection #treatment #OpenAccess

@cancers-mdpi.bsky.social Oct 9, 2026, 7:32 AM

🧩Editor’s Choice

#Immunotherapies for #BreastCancer: From Checkpoint Inhibition to Emerging Cellular Therapies
🧑‍⚕️by Ismini Tsagkaraki, Isaac Gannon et al.
🏥 @royalberkshospital.bsky.social, @uclh.bsky.social
📈6 citations
Link🔗 www.mdpi.com/2072-6694/18...

#TNBC #ICIs #CART #CARNK

Figure 1. Different immunotherapeutic approaches targeting breast cancer. Antibody-based therapies, Tumour Infiltrating Lymphocytes, TCR-Targeting T-cells and CAR-T cell therapies are highlighted here. Advantages and disadvantages of each modality are highlighted with either a green check mark or a red cross respectively. In the middle, the most promising antigenic targets for TCR and CAR-T cell therapies are presented.

@cancers-mdpi.bsky.social Oct 8, 2026, 8:47 AM

🎯Editor's Choice
Single-Cell Comparison of Small Intestinal #NeuroendocrineTumors and #Enterochromaffin Cells from Two Patients
🧑‍🔬by Fredrik Axling, Elham Barazeghi et al. from Uppsala University
Find out more👉 www.mdpi.com/2072-6694/18...

#SINET #RNAseq #transcriptomics

Figure 1. UMAP plots of cells from the discovery dataset. (A) SI-NET Resected Tumor cells (n = 3544). (B) Ileum Resected Tissue cells (n = 5419). (C) Enterochromaffin (EC) vs. SI-NET cells (n = 76 vs. 30). Identified cell types include activated T-lymphocytes, T-lymphocytes, differentiated enterocytes, dendritic cells, crypt-like enterocytes, transit-amplifying cells, erythrocytes, monocytes, plasma cells, effector B cells, mast cells, mesenchymal/fibroblasts, endothelial cells, goblet cells, tuft cells, enterochromaffin (EC) cells, and SI-NET cells.

@cancers-mdpi.bsky.social Oct 8, 2026, 6:45 AM

🧩Editor's Choice
Clinical Validity of NETest2.0® in Surveillance of #NeuroendocrineTumor Patients: Evidence from a #NET Registry Study (NCT02270567)
👥Anthony Gulati, Diane Reidy et al.
Full text➡️ www.mdpi.com/2072-6694/18...
🗝️Keywords: #biomarker; liquid biopsy; #mRNA
@dukecancer.bsky.social

Figure 2. STARD diagram showing an overview of the design, cohort selection, and outcome stratification for Objective 2. Abbreviations: IPD: image-positive disease, IND: image-negative disease; R0: margin-negative curative surgery; PD: progressive disease; SD: stable disease. Responders include stable disease (SD), partial responses (PR), and complete responses (CR). Non-responders are identified as progressive disease (PD). IQR = interquartile range.

@cancers-mdpi.bsky.social Sep 30, 2026, 9:22 AM

🤗Meet Us at the 27th #IPOS World Congress!

Date🗓️: 9–12 Nov 2026
Location📍: Barcelona, Spain
Booth🪧: #1
More details🔗: www.mdpi.com/about/announ...

#CancersMDPI #MDPIconference #PsychoOncology #survivorship #PalliativeCare #DigitalHealth #CancerCare #IPOS2026 @ipospsychooncol.bsky.social

@cancers-mdpi.bsky.social Sep 30, 2026, 5:05 AM

🏅Editor's Choice
#Survival Impact of Textbook Oncological Outcomes and SDHs for Patients with Operable #EsophagealCancer
🧑‍⚕️by Ahmed Alnajar, Nestor Villamizar et al.
Welcome to read here🔗 www.mdpi.com/2072-6694/18...
#SurgicalQuality #SurvivalDisparities

Figure 2. KM Curves by SDH status, stratified by TOO and stage (8 panels). Footnote: Panels (A–D) depict overall survival among patients who achieved textbook oncological outcomes (TOO+) stratified by SDH status (favorable [+] vs. unfavorable [−] SDH) for Stage I (A), Stage II (B), Stage III (C), and Stage IVa (D) esophageal cancer.

@cancers-mdpi.bsky.social Sep 29, 2026, 5:27 AM

🎯Editor's Choice
A Narrative Review of European Registries for #SkinCancer: Where Are We and Where Should We Be?
✍️ By Alexander Katalinic, Karima Hammas et al.
Citations: 6✅
Find out more👉 www.mdpi.com/2072-6694/18...
#CancerRegistration #incidence #melanoma

Figure 1. Coverage of cancer registration in Europe in 2025, based on the ENCR-associated registries list. Source: European Network of Cancer Registries

@cancers-mdpi.bsky.social Sep 28, 2026, 7:37 AM

🌟We are delighted to share some highly cited #SpecialIssues in 2025 related to "Cancer Therapy" in Cancers (ISSN 2072-6694)!

🔎Explore them at the link: www.mdpi.com/journal/canc...

#CancerTherapy #Oncology #Management #Surgery

@cancers-mdpi.bsky.social Sep 28, 2026, 5:24 AM

📢Meet us at the 𝟐𝟎𝟐𝟔 𝐇𝐮𝐦𝐚𝐧 𝐏𝐫𝐨𝐭𝐞𝐨𝐦𝐞 𝐎𝐫𝐠𝐚𝐧𝐢𝐳𝐚𝐭𝐢𝐨𝐧 𝐖𝐨𝐫𝐥𝐝 𝐂𝐨𝐧𝐠𝐫𝐞𝐬𝐬 #HUPO2026 !
📆27 September–1 October 2026
🌏Singapore
📍Booth #242
🔗 2026.hupo.org
#MDPIConference #CancersMDPI #OncologyResearch #proteome #proteomics @hupo-org.bsky.social

@cancers-mdpi.bsky.social Sep 28, 2026, 3:34 AM

🥳We are pleased to announce that Prof. Dr. Tadeusz Robak has been appointed as the Section Editor-in-Chief of "Cancer Therapy"!

📰Check out the short Q&A, including his vision for the journal and views on the research area and open-access publishing: www.mdpi.com/about/announ...

#CancerTherapy

@cancers-mdpi.bsky.social Sep 24, 2026, 3:20 AM

👏Thrilled to share our highly cited #SpecialIssues in 2025 related to cancer #informatics and #BigData in Cancers!

Explore them by clicking the link👉 www.mdpi.com/about/announ...

#bioinformatics #ArtificialIntelligence #biostatistics #sequencing

@cancers-mdpi.bsky.social Sep 24, 2026, 3:02 AM

📸We are at the 85th Annual Meeting of the Japanese Cancer Association! Welcome to our booth # N12 for communication🤗

🗓️24 Sep 2026 - 26 Sep 2026
📍Kyoto, Japan
🔗 www.c-linkage.co.jp/jca2026/en/p...
#CancersMDPI #OncologyResearch #MDPIJapan #JapaneseCancerAssociation

@cancers-mdpi.bsky.social Sep 23, 2026, 8:43 AM

👏We are proud to welcome 18 new Editorial Board Members to Cancers (August 2026). Wishing our new EBMs huge success in their research and journal contributions! 🌟
🔗Read more: www.mdpi.com/about/announ...
#CancersMDPI #Oncology #Research #OpenAccess

@cancers-mdpi.bsky.social Sep 23, 2026, 8:38 AM

📣Check out some highly cited #SpecialIssues in 2025 related to our section "Tumor Microenvironment"

Explore here🔎 www.mdpi.com/about/announ...

#TumorMicroenvironment #metastasis #angiogenesis #IntercellularCommunication @mdpiopenaccess.bsky.social

@cancers-mdpi.bsky.social Sep 22, 2026, 6:49 AM

🌟We are delighted to share some highly cited #SpecialIssues in 2025 related to Section "Cancer #Epidemiology and #Prevention" in Cancers

Click the link below📌 www.mdpi.com/about/announ...
#CancerPrevention #CancerRisk #PublicHealth #CancersMDPI @mdpiopenaccess.bsky.social

@cancers-mdpi.bsky.social Sep 21, 2026, 2:38 AM

👏Thrilled to share our highly-cited #SpecialIssues in 2025 Related to Cancer #Biomarkers!

Explore here🔎 www.mdpi.com/about/announ...

#CancerBiomarker #markers #predictor #oncology

@cancers-mdpi.bsky.social Sep 20, 2026, 5:33 AM

🔥Excited to sponsor the 37th Annual Meeting of the European Society for #Hyperthermic Oncology ( #ESHO)! Meet in Erlangen to discover groundbreaking advancements and engage with leading experts.
🗓Oct 4–6, 2026
📍Erlangen, Germany
🔗Event details: esho-congress.eu
#HyperthermicOncology #ThermalTherapy

@cancers-mdpi.bsky.social Sep 18, 2026, 7:46 AM

📢Check out the highly cited #SpecialIssues in 2025 related to “Cancer Drug Development”

Link to the collection🔗 www.mdpi.com/about/announ...
#CancerDrug #resistance #TargetedDrugs #DrugDiscovery

@cancers-mdpi.bsky.social Sep 18, 2026, 5:03 AM

🗂️We are delighted to share some highly cited #SpecialIssues in 2025 in the "Clinical Research in Cancer" Section in Cancers

Explore them via this link👉 www.mdpi.com/about/announ...
#ClinicalResearch #ClinicalOutcome #TranslationalResearch #CancersMDPI

@cancers-mdpi.bsky.social Sep 17, 2026, 10:16 AM

🧬Spatial #Transcriptomics in #LungCancer and Pulmonary Diseases: A Comprehensive Review

🧑‍🔬by Da Hyun Kang, Yoonjoo Kim et al. from Chungnam National University

📊Cited 19 times!

Read it here🔗 www.mdpi.com/2072-6694/17...

#SpatialTranscriptomics #PulmonaryDisease #TumorMicroenvironment

Figure 4. Spatial transcriptomic signatures across pulmonary diseases: cellular niches and molecular pathways.

Older posts